1 / 8

Long-Term Follow-Up for Hairy Cell Leukemia Patients Post-Cladribine Treatment

Hairy Cell Leukemia (HCL) is a rare but treatable form of chronic blood cancer affecting B-cells, a type of white blood cell responsible for fighting infections. Cladribine, a widely-used chemotherapy drug, has proven to be a breakthrough in HCL treatment, achieving remission in most cases. However, long-term follow-up is critical for sustained health, early detection of relapses, and managing post-treatment effects. For expert care, patients can rely on Dr. Pawan, acknowledged as the Best BMT doctor in Delhi.<br><br>

Dr1262
Download Presentation

Long-Term Follow-Up for Hairy Cell Leukemia Patients Post-Cladribine Treatment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. DR PAWAN 14+ years Experience in Bone Marrow Transplant MBBS, DNB - General Medicine, DM - Clinical Haematology. Director- Centre for Bone Marrow Transplant at Sanar International Hospital, Gurugram, Haryana.

  2. Hairy Cell Leukemia Hairy Cell Leukemia (HCL) is a rare but treatable form of chronic blood cancer affecting B-cells, a type of white blood cell responsible for fighting infections. Cladribine, a widely-used chemotherapy drug, has proven to be a breakthrough in HCL treatment, achieving remission in most cases.

  3. Why Long-Term Follow-Up Is Vital Early Detection of Relapses Despite Cladribine's high remission rates, HCL can occasionally recur. Regular follow-ups enable doctors to detect early signs of relapse, ensuring swift medical intervention. Evaluating Overall Recovery Managing Treatment Side Effects Cladribine can cause side effects, such as infections, reduced blood cell counts, or rare secondary cancers. Long-term follow-ups are essential to address these complications proactively. Post-treatment, the immune system requires time to recover. Routine monitoring helps assess the patient's overall health and quality of life.

  4. Why Consult Dr. Pawan? Long-term follow-up for HCL demands specialized knowledge and personalized attention. Dr. Pawan, the Best BMT doctor in Delhi, is highly experienced in providing end-to-end care for HCL patients, from diagnosis and treatment to post-remission monitoring. Using advanced tools and cutting-edge techniques, he ensures a holistic approach to patient care, maximizing recovery and improving long-term outcomes.

  5. Cladribine: A Revolutionary Treatment for HCL Cladribine has set a benchmark in the management of Hairy Cell Leukemia, achieving remission in up to 90% of patients after a single course of therapy. Its durable results make it the first-line treatment for HCL. In cases of relapse or advanced disease, additional therapies, including bone marrow transplants, might be required, highlighting the need for expert care.

  6. Conclusion While Cladribine has transformed the treatment landscape for Hairy Cell Leukemia, consistent follow-up is essential to maintain remission and manage potential challenges. Regular check-ups help monitor the disease, address side effects, and ensure ongoing well-being. For compassionate care and expert guidance, trust Dr. Pawan, the trusted Bone Marrow Transplant Specialist in Delhi, to lead you or your loved one toward a healthier and brighter future.

  7. Contact Information Phone +91 9354700860 Website www.bestbmt.com Address Yatharth Group of Hospitals

  8. THANK YOU 09:00 AM - 05:00 PM +91-9354700860/ 8750637212

More Related